Although the mechanisms by which CD8+ Treg-of-B cells alleviated colitis were unclear in this study, our findings suggested that CD8+ Treg-of-B cells might participate in regulating intestinal homeostasis and support the therapeutic potential of CD8+ Tregs in IBD. This evidence concerns the gene CD8A and colitis.